Salvarx Share Discussion Threads

[bandflex] 14/8/2018 10:50

If the deal goes through and you want to keep Portage shares its worth bearing this in mind -

"The CSE is a junior stock market in Canada and is not widely traded by investors in the UK. A number of UK-based brokers do, however, offer a trading platform for investors to dematerialise their Demerger Shares (should they wish to do so) and deal in Portage Shares electronically. Shareholders wishing to hold their Demerger Shares in dematerialised form should, in the first instance, speak to their existing broker to see whether they provide this service. If they do not provide this service Shareholders should contact other brokers."

[bandflex] 14/8/2018 10:45

Jim Mellon is a director of Portage, Ian Walters the CEO of SALV is on the Portage board though he isn't shown on the Portage website. Very much a related party deal.

As it is an all share deal it will be interesting to see what happens to the Portage share price when the markets open.

Portage (PTGEF) yesterday closed at 10c with a market cap of $28m, they are offering $65.7m in shares for SALV.

Portage shareholders have yet to vote on this and no timing has been announced yet, it will mean massive dilution for them.

Demerger shares can only be traded in Canada.

SALV intends to become a cash shell if the deal goes through.

Value to SALV shareholders depends entirely on direction of Portage share price and Portage shareholders voting yes to the deal.

[the stigologist] 14/8/2018 10:34

This is basically a Reverse Takeover

Portage after paying out their cash winnings from previous investments were looking for investments, they get to buy SALV on the cheap and take it over to the Canadian market where they have a great reputation amongst that Investor base

I think SALV now goes from strength to strength

Will be holding my SALV and looking for 400p+

[shakyhands] 14/8/2018 10:31

Found the Canada listing - PBT.U Only looked because they said Canadian listed in the announcement.

[shakyhands] 14/8/2018 10:31

Found the Canada listing - PBT.U Only looked because they said Canadian listed in the announcement.

[kristini2] 14/8/2018 10:14

that's it on the OTC i think

They are offering the GBP equivalent of circa £1.40 so why sell at this price ?

[shakyhands] 14/8/2018 10:09

I couldn't find Portage in Canada - just the OTC.

[shakyhands] 14/8/2018 10:09

I couldn't find Portage in Canada - just the OTC.

[dexdringle] 14/8/2018 09:57

Dear The Stig

Oh I see.....free money......people buying at 90p are still going to get guaranteed free money in the future....

Thanks for clearing that up. There was me thinking that the market price (90p) reflected the likely benefits in full.

I paid 34p each for these. I suspect that qualifies me not to be categorised as a "fekking idiot". I could be wrong....

[letmepass] 14/8/2018 09:47

250% premium from 40p..

[zen12] 14/8/2018 09:46

Dex - don’t understand your post. Read the rns out today!

[the stigologist] 14/8/2018 09:29

No you fekking idiot, you get to continue to participate in the upside which will be unlocked by this transaction

[dexdringle] 14/8/2018 08:22

I can't believe people are buying

Surely, if you rated these you'd have bought them before the announcement ?

What is the point of buying now ? Has the boat not already left the jetty......

[the stigologist] 14/8/2018 08:21

Actually this looks really good.

Portage are value creators. We can continue to participate in upside by holding our shares.

They basically seem to be saying. Let's clean up the structure. Let's fund these companies to next stage. Have a liquidity event. Then we'll pay out cash.


-- Shareholders who continue to hold SalvaRx shares will also receive 18 Demerger Shares (i.e. Portage shares) for every share in SalvaRx held on the Demerger Record Date, equivalent to approximately US$1.80* per SalvaRx share

-- Portage has existing interests in four promising biotech companies and cash resources of approximately US$7.3 million which will be used to fund the ongoing development of the portfolio of oncology assets owned by SalvaRx Limited

-- Portage has a history of creating value for its shareholders - one of its portfolio companies, Biohaven Pharmaceutical Holding Company Ltd ("Biohaven") (NYSE:BHVN), was the second largest biotech IPO on NASDAQ in 2017. Portage subsequently announced a distribution in specie of its stock in Biohaven to its shareholders

[spectoacc] 14/8/2018 08:21

I'd guess it's the fact it's in shares, listed in Canada, rather than in cash.

Would love to claim some credit for SALV but am no longer a holder - well done those who are.

[the stigologist] 14/8/2018 08:17

Because the consideration is in Portage shares it will depend how well Portage sell the deal to their Investor base. If Portage shares go up on back of deal announcement then we could see much higher than 100p.

The see thru value right now should be close to 180c

[andrbea] 14/8/2018 08:17

good news today
currently up 124%
why not 250% (see rns)?

" Consideration Shares valued at approximately US$75.8 million, representing a premium of over 250% to the current market valuation of SalvaRx*"

[dexdringle] 14/8/2018 08:16

Am hoping some clever person is going to come on here soon and explain what the hell the announcement really means. Shares, consideration shares, demerger shares, 100% of 94%, premium 250%, 18 demerger shares of $1.80 each for every existing share, bonus based on CEO's inside leg measurement (I made that last one up)....

Price appears to have gone up by 3p. Presumably therefore the value is in the mysterious 18 for 1 demerger shares that come later ?

08:19 EDIT the price is 90p now - ADVFN chart way off

[blueball] 14/8/2018 08:11

100p today no doubt.

[the stigologist] 14/8/2018 08:11

Just a bit !

I wonder if there is any chance of an alternative (higher) offer coming in?

Let's face it this in an 'inside' job. They know the value of the portfolio. (seen talk of multiples of 100p before) so will any other entity want to get involved ?

[amrishbhim] 14/8/2018 07:53

Excellent, should be a good day on here today

[the stigologist] 14/8/2018 07:36

Explains the recent interest. Obviously something must have leaked but the stock was way undervalued so it was only a matter of time

[the stigologist] 14/8/2018 07:35

Highlights

· Consideration Shares valued at approximately US$75.8 million, representing a premium of over 250% to the current market valuation of SalvaRx*


· Shareholders who continue to hold SalvaRx shares will also receive 18 Demerger Shares (i.e. Portage shares) for every share in SalvaRx held on the Demerger Record Date, equivalent to approximately US$1.80* per SalvaRx share


· Portage has existing interests in four promising biotech companies and cash resources of approximately US$7.3 million which will be used to fund the ongoing development of the portfolio of oncology assets owned by SalvaRx Limited

[kristini2] 03/8/2018 11:58

Aim, totally illogical market with bizarre price movements